High-Ranking FDA Official Drops Jaw-Dropping Confession
Dr. Sara Brenner, a senior official at the U.S. Food and Drug Administration (FDA), recently disclosed that she chose not to receive a COVID-19 vaccine due to concerns surrounding how the vaccine might distribute within the body, particularly during pregnancy and breastfeeding. Speaking at a Washington, D.C. event on May 15, she explained that, during the pandemic, there was limited information available about the biodistribution of the vaccine and whether any components might be transferred through breast milk, which prompted her to abstain from vaccination while pregnant.
Brenner noted that subsequent research has supported her caution. Studies published in 2022 and 2023 identified traces of messenger RNA—the active component in Pfizer and Moderna vaccines—in human breast milk. While these findings have generated ongoing discussion, both pharmaceutical companies declined to comment. Brenner emphasized she was not representing the FDA in her statements but expressed that, in hindsight, she believes her decision was justified based on the data now available.
At the same event, hosted by the MAHA Institute—an organization promoting public health reform under the slogan “Make America Healthy Again”—Brenner emphasized the importance of transparency and honest communication in public health. She critiqued previous government messaging around COVID-19 for failing to acknowledge the unknowns and for promoting assumptions as facts. Brenner, who has a background in nanotechnology and preventive medicine, said that being open about scientific uncertainties is vital for restoring public trust.
Her remarks came as federal agencies begin shifting their stance on routine COVID-19 vaccination. A health official confirmed that recommendations for universal vaccination among children and pregnant women are being reconsidered. This change reflects a broader reevaluation of pandemic policies and public health messaging, with officials like Brenner advocating for clearer, more evidence-based guidance going forward.
Having served in both the Trump and Biden administrations, Brenner spoke of a shift in government culture, suggesting the current leadership is more open to reevaluating past approaches. She expressed hope that the public will see greater access to reliable data and a more transparent decision-making process, which she sees as essential to improving future health policy and government credibility.
Discussion about this post